Trading Desks to Clinical Trials: Parallels in Applied Vertical AI — Ayush Bhardwaj, Allos AI @aiDotEngineer
Trading Desks to Clinical Trials: Parallels in Applied Vertical AI — Ayush Bhardwaj, Allos AI  @aiDotEngineer
Uploaded August 2026 | Updated September 2026, 3 weeks ago
Ayush Bhardwaj could build the agent. What he could not do was tell whether it was any good. He moved from applied AI at a hedge fund to a pharma tech company expecting a different world, and found the job identical, including the wall. An engineer glances at generated code and knows instantly that it is weak, because years of training built that judgment. Nobody on his team had the equivalent instinct for a trade thesis or a drug candidate. He calls this the point where vertical AI projects quietly die, because the thing looks finished and then nobody buys it.

Judging his way out with a model was, in his words, a stupid mistake, since it jargons its way through without knowing what alpha means. Verifiable rewards work for math and code because answer keys exist. Worse, the data that would teach a model to reason in these fields is deliberately withheld. Funds must file their holdings quarterly, and their returns drop once competitors reverse engineer them. Disclosing every clinical trial is legally required, yet roughly 30% of firms never do, and in 2026 the FDA publicly reminded more than 2,000 sponsors. The frontier labs do not have it either. So his answer is to hire the user, which for a team of young engineers meant hiring a senior scientist, after which their tools started speaking big pharma's language. That expert curates sources, sharpens prompts and does the judging, starting from error analysis as the cheapest rung. The moat is never the model or the infrastructure. Both are commodities.

Speaker info:
- https://x.com/aybh08
- linkedin.com/in/aybh
- ayushb.me

Timestamps:
0:00 - Reading the room
1:04 - What applied vertical AI actually means
2:43 - Leaving a hedge fund for pharma and changing nothing
3:34 - The wrong question about agents in production
4:27 - Step one, make the task narrow
5:18 - Proprietary data is the only real differentiator
6:57 - The easy part fits on one screen
7:50 - Why you cannot iterate on what you cannot judge
9:30 - Trying to use a model as the judge
10:21 - The data was never there, by design
12:05 - Hire the user
12:55 - Building the learning loop around a domain expert
14:39 - From error analysis up to preference training
16:20 - Reaching production is not the same as working
17:10 - The seven steps
18:00 - AI in the loop, not human in the loop
19:00 - Your moat is domain expertise and data
Trading Desks to Clinical Trials: Parallels in Applied Vertical AI — Ayush Bhardwaj, Allos AIAnthropics CCA Exam as a Field-Guide for Agentic Engineering — Frank Coyle, UC BerkeleyTeaching AI to Find Real Vulnerabilities — Prof. David Brumley, BugcrowdBuilding the Engine While Flying the Plane: Launching the Figma MCP Server — Jesse Lumarie, FigmaBringing Continual Learning into Enterprises — Samuel Denton, Applied ComputeAgent Spending Without Controls — Rodrigo Coelho & Pranav Maheshwari, Edge & NodeState of Data — Sean Cai, Independent / State of DataRL Environments at Scale – Will Brown, Prime IntellectData Quality Is the Compute Multiplier — Ari Morcos, DatologyAIThe Era of Compound Engineering — Kieran Klaassen, Every/CoraAgents, codebases, and teams — Aditya Khandelwal, Amazon AGI LabAI Evals for Cross-Functional Teams — Nachiket Paranjape & Swaroop Chitlur Haridas, DoorDash
AI Engineer |

Trading Desks to Clinical Trials: Parallels in Applied Vertical AI — Ayush Bhardwaj, Allos AI

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER